AHR (American Healthcare REIT, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by AHR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Mark E. Foster | EVP, GC & Secretary | Sell | — | — |
| 2026-08-04 | Danny Prosky | Director | A | — | — |
| 2026-07-22 | Jeffrey T Hanson | Chief Executive Officer | A | — | — |
| 2026-07-22 | Gabriel M Willhite | President & COO | A | — | — |
| 2026-07-22 | Danny Prosky | Director | MIXED | — | — |
| 2026-06-29 | BRIAN PEAY | Chief Financial Officer | Sell | — | — |
| 2026-06-26 | Brian J. Flornes | Director | A | — | — |
| 2026-06-26 | Marvin R O'Quinn | Director | A | — | — |
| 2026-06-26 | Mark E. Foster | EVP, GC & Secretary | Sell | — | — |
| 2026-06-26 | SCOTT A ESTES | Director | A | — | — |
| 2026-06-26 | Dianne Hurley | Director | A | — | — |
| 2026-06-26 | Mathieu B. Streiff | Director | A | — | — |
| 2026-06-26 | Valerie Richardson | Director | A | — | — |
| 2026-06-26 | Wilbur H Smith III | Director | A | — | — |
| 2026-06-03 | Mark E. Foster | EVP, GC & Secretary | Sell | — | — |
| 2026-04-08 | Danny Prosky | Director | MIXED | — | — |
| 2026-04-08 | BRIAN PEAY | Chief Financial Officer | MIXED | — | — |
| 2026-04-08 | Gabriel M Willhite | Chief Operating Officer | MIXED | — | — |
| 2026-04-08 | Stefan K.L. Oh | Chief Investment Officer | MIXED | — | — |
| 2026-04-08 | Mark E. Foster | EVP, GC & Secretary | MIXED | — | — |
| 2026-03-30 | Jeffrey T Hanson | Interim CEO and President | A | — | — |
| 2026-03-27 | Danny Prosky | Director | MIXED | — | — |
| 2026-03-27 | BRIAN PEAY | Chief Financial Officer | MIXED | — | — |
| 2026-03-27 | Gabriel M Willhite | Chief Operating Officer | MIXED | — | — |
| 2026-03-27 | Stefan K.L. Oh | Chief Investment Officer | MIXED | — | — |
| 2026-03-27 | Mark E. Foster | EVP, GC & Secretary | MIXED | — | — |
| 2026-03-16 | Danny Prosky | Director | MIXED | — | — |
| 2026-03-16 | BRIAN PEAY | Chief Financial Officer | MIXED | — | — |
| 2026-03-16 | Gabriel M Willhite | Chief Operating Officer | MIXED | — | — |
| 2026-03-16 | Stefan K.L. Oh | Chief Investment Officer | MIXED | — | — |
| 2026-03-16 | Mark E. Foster | EVP, GC & Secretary | MIXED | — | — |
| 2026-02-11 | Danny Prosky | CEO & President | F | — | — |
| 2026-02-11 | BRIAN PEAY | Chief Financial Officer | F | — | — |
| 2026-02-11 | Gabriel M Willhite | Chief Operating Officer | F | — | — |
| 2026-02-11 | Stefan K.L. Oh | Chief Investment Officer | F | — | — |
| 2026-02-11 | Mark E. Foster | EVP, GC & Secretary | F | — | — |
| 2025-12-29 | Jeffrey T Hanson | Director | Sell | — | — |
| 2025-11-12 | Mark E. Foster | EVP, GC & Secretary | Sell | — | — |
| 2025-11-10 | Jeffrey T Hanson | Director | Sell | — | — |
| 2025-09-05 | Mark E. Foster | EVP, GC & Secretary | Sell | — | — |
| 2025-07-02 | Stefan K.L. Oh | Chief Investment Officer | Sell | — | — |
| 2025-06-27 | Jeffrey T Hanson | Director | A | — | — |
| 2025-06-27 | SCOTT A ESTES | Director | A | — | — |
| 2025-06-27 | Brian J. Flornes | Director | A | — | — |
| 2025-06-27 | Dianne Hurley | Director | A | — | — |
| 2025-06-27 | Valerie Richardson | Director | A | — | — |
| 2025-06-27 | Wilbur H Smith III | Director | A | — | — |
| 2025-06-27 | Mathieu B. Streiff | Director | A | — | — |
| 2025-06-27 | Marvin R O'Quinn | Director | A | — | — |
| 2025-04-07 | Danny Prosky | CEO & President | M | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 514,995 | — |
| — | Director | 192,373 | — |
| — | Chief Financial Officer | 153,507 | — |
| — | President & COO | 151,819 | — |
| — | Chief Investment Officer | 96,994 | — |
| — | EVP, GC & Secretary | 51,617 | — |
| — | Director | 35,013 | — |
| — | Director | 34,037 | — |
| — | Director | 33,020 | — |
| — | Chief Executive Officer | 22,527 | — |
| — | Director | 21,489 | — |
| — | Director | 20,656 | — |
| — | Director | 20,656 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AHR quote page; the site-wide leaderboard is on the insider transactions hub.